The KPNA1 Knockout NCI-H1975 Polyclonal Cells product provides a CRISPR/Cas9-edited polyclonal knockout cell population for studying nucleocytoplasmic transport and signaling in lung adenocarcinoma. This heterogeneous pool of cells carries various CRISPR-induced disruptions in the KPNA1 gene, resulting in loss of importin ??5 function without clonal selection, thereby preserving population-level relevance and minimizing clonal artifacts. The polyclonal format is suitable for functional assays where averaging effects across edited alleles reflects the overall biological consequence of KPNA1 disruption.
The host cell line, NCI-H1975, is a widely used human non-small cell lung adenocarcinoma epithelial cell line harboring activating EGFR L858R and gatekeeper T790M mutations. These mutations drive constitutive EGFR signaling and confer resistance to first-generation tyrosine kinase inhibitors (TKIs), making this line essential for investigating mechanisms of acquired drug resistance and oncogenic signaling in lung cancer. The adherent epithelial morphology and well-characterized genomic background support robust in vitro experiments.
KPNA1 encodes importin ??5, a nuclear import adaptor that selectively binds classical nuclear localization signal (NLS)-containing cargo proteins and links them to importin ??1 (KPNB1) for translocation through the nuclear pore complex. Inside the nucleus, RanGTP binding dissociates the import complex, releasing cargo and recycling importins. KPNA1 mediates nuclear import of transcription factors such as NF-??B p65, STAT1, p53, and co-regulators like PD-L1, thereby regulating key pathways including NF-??B, JAK-STAT, and p53 signaling. It interacts with FG-repeat nucleoporins (e.g., NUP153, NUP62) during translocation, placing it at the nexus of nucleocytoplasmic trafficking and transcriptional control.
Disruption of KPNA1 in NCI-H1975 cells offers a powerful model to dissect how attenuated nuclear import of specific transcription factors alters oncogenic signaling and drug responses. For instance, impaired NF-??B p65 nuclear accumulation may reduce transcriptional activation of survival and proliferation genes, potentially sensitizing cells to EGFR TKIs or chemotherapeutics. Similarly, altered STAT1 shuttling could impact interferon-related signaling and immune evasion phenotypes. This model thus enables mechanistic study of importin ??5-dependent pathways in a clinically relevant TKI-resistant lung adenocarcinoma context.
Researchers can employ this knockout model in a range of applications: western blotting to confirm KPNA1 depletion; immunofluorescence to visualize mislocalization of NLS-bearing cargoes such as NF-??B p65 or STAT1; nuclear-cytoplasmic fractionation for quantitative import assays; RNA-seq to profile transcriptomic changes; cell proliferation (MTT) and apoptosis assays; migration/invasion studies; and drug sensitivity testing with EGFR TKIs or cisplatin. For further technical details or custom inquiries, please contact Ascent Research.
